目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Pain
1.2.3. Route of Administration
1.2.4. Distribution channel
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Drug class and pain outlook
2.2.2. Route of administration and distribution channel outlook
2.3. Competitive Insights

Chapter 3. Non-opioid Pain Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High prevalence of chronic & inflammatory diseases globally
3.2.1.2. Increasing product approvals and launches
3.2.1.3. Supportive regulatory and reimbursement policies
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations
3.2.2.2. Side-effects associated with drug
3.3. Non-opioid Pain Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Pricing Analysis

Chapter 4. Non-opioid Pain Treatment Market: Drug Class Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Non-opioid Pain Treatment Market: Drug Class Movement Analysis
4.3. Global Non-opioid Pain Treatment Market Estimates and Forecasts, By Drug, Class Revenue (USD Million)
4.4. NSAIDs
4.4.1. NSAIDs market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Non-Selective NSAIDs
4.4.2.1. Non-Selective NSAIDs market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Selective COX-2 Inhibitors
4.4.3.1. Selective COX-2 Inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Acetaminophen
4.5.1. Acetaminophen market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Local Anesthetics
4.6.1. Local Anesthetics market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Other Drug Class
4.7.1. Others drug class market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Non-opioid Pain Treatment Market: Pain Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Non-opioid Pain Treatment Market: Pain Movement Analysis
5.3. Global Non-opioid Pain Treatment Market Estimates and Forecasts, By Pain, Revenue (USD Million)
5.4. Post-operative Pain
5.4.1. Post-operative pain market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Cancer Pain
5.5.1. Cancer pain market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Chronic Pain
5.6.1. Chronic pain market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Other Pain
5.7.1. Other pain market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Non-opioid Pain Treatment Market: Route of Administration Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Non-opioid Pain Treatment Market: Route of Administration Movement Analysis
6.3. Global Non-opioid Pain Treatment Market Estimates and Forecasts, By Route of Administration, Revenue (USD Million)
6.4. Oral
6.4.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Topical
6.5.1. Topical market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Injectable
6.6.1. Injectable market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Other Route of Administration
6.7.1. Other route of administration market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Non-opioid Pain Treatment Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Non-opioid Pain Treatment Market: Distribution Channel Movement Analysis
7.3. Global Non-opioid Pain Treatment Market Estimates and Forecasts, by Distribution Channel, Revenue (USD Million)
7.4. Hospitals Pharmacies
7.4.1. Hospitals pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Retail Pharmacies
7.5.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Online Pharmacies
7.6.1. Online Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Non-opioid Pain Treatment Market: Regional Estimates & Trend Analysis By Drug Clas, Pain, Route of Administration, and Distribution Channel
8.1. Regional Dashboard
8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.3.3. Mexico
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework/ reimbursement structure
8.3.3.3. Competitive scenario
8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Argentina
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. Key company market share analysis, 2024
9.3.2. Novartis AG
9.3.2.1. Company overview
9.3.2.2. Financial performance
9.3.2.3. Product benchmarking
9.3.2.4. Strategic initiatives
9.3.3. Teva Pharmaceutical Industries Limited
9.3.3.1. Company overview
9.3.3.2. Financial performance
9.3.3.3. Product benchmarking
9.3.3.4. Strategic initiatives
9.3.4. Teva Pharmaceutical Industries Limited
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Sun Pharmaceutical Industries Ltd
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. GSK plc.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Pfizer Inc.
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Perrigo Company plc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. LNK International, Inc.
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Cipla Inc.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Johnson & Johnson Services, Inc.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Pacira Pharmaceuticals, Inc.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Pierrel
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 List of key distributors
Table 4 List of other companies
Table 5 List of key emerging company’s/technology disruptors/innovators
Table 6 North America Non-Opioid Pain Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 7 North America Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 8 North America Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 9 North America Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 10 North America Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 11 U.S. Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 12 U.S. Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 13 U.S. Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 14 U.S. Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 15 Canada Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 16 Canada Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 17 Canada Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 18 Canada Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 19 Mexico Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 20 Mexico Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 21 Mexico Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 22 Mexico Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 23 Europe Non-Opioid Pain Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 24 Europe Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 25 Europe Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 26 Europe Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 27 Europe Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 UK Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 29 UK Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 30 UK Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 31 UK Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Germany Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 33 Germany Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 34 Germany Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 Germany Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 France Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 37 France Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 38 France Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 39 France Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Spain Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 41 Spain Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 42 Spain Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 43 Spain Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Italy Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 45 Italy Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 46 Italy Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 47 Italy Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Denmark Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 49 Denmark Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 50 Denmark Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 51 Denmark Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 Sweden Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 53 Sweden Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 54 Sweden Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 55 Sweden Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 Norway Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 57 Norway Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 58 Norway Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 59 Norway Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Japan Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 65 Japan Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 66 Japan Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 67 Japan Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 China Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 69 China Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 70 China Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 71 China Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 India Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 73 India Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 74 India Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 75 India Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Australia Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 77 Australia Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 78 Australia Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 79 Australia Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 South Korea Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 81 South Korea Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 82 South Korea Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 83 South Korea Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 Thailand Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 85 Thailand Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 86 Thailand Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 87 Thailand Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 Latin America Non-Opioid Pain Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 89 Latin America Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 90 Latin America Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 91 Latin America Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 92 Latin America Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 93 Brazil Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 94 Brazil Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 95 Brazil Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 96 Brazil Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 97 Argentina Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 98 Argentina Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 99 Argentina Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 100 Argentina Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 101 MEA Non-Opioid Pain Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 102 MEA Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 103 MEA Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 104 MEA Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 105 MEA Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 106 South Africa Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 107 South Africa Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 108 South Africa Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 109 South Africa Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 114 UAE Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 115 UAE Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 116 UAE Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 117 UAE Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 118 Kuwait Non-Opioid Pain Treatment Market, By Drug Class Class, 2018 - 2030 (USD Million)
Table 119 Kuwait Non-Opioid Pain Treatment Market, By Pain, 2018 - 2030 (USD Million)
Table 120 Kuwait Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 121 Kuwait Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Non-opioid pain treatment market Segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Non- opioid pain treatment market snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook, revenue, 2024 (USD Million)
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Non- opioid pain treatment market driver impact
Fig. 14 Non- opioid pain treatment market restraint impact
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Industry Analysis - Porter's Five Forces
Fig. 17 Strategy mapping
Fig. 18 Non-opioid pain treatment market: Drug class outlook and key takeaways
Fig. 19 Non- opioid pain treatment market: Drug class movement analysis & market share 2024 & 2030
Fig. 20 NSAIDs non-opioid treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Non-selective NSAIDs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Selective COX-2 inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Acetaminophen market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Local Anesthetics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Other drug class market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Non-opioid treatment market: Pain outlook and key takeaways
Fig. 27 Non-opioid treatment market: Pain movement analysis & market share 2024 & 2030
Fig. 28 Post-operative pain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Cancer pain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Chronic pain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Other pain non-opioid treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Non- non-opioid treatment market: Distribution channel outlook and key takeaways
Fig. 33 Non- non-opioid treatment market: Distribution channel movement analysis & market share 2024 & 2030
Fig. 34 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Global Non-opioid Pain Treatment market: Regional movement analysis
Fig. 38 Global Non-opioid Pain Treatment market: Regional outlook and key takeaways
Fig. 39 Global Non-opioid Pain Treatment market share and leading players
Fig. 40 North America, by country
Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 U.S. key country dynamics
Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Canada key country dynamics
Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Mexico key country dynamics
Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 UK key country dynamics
Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Germany key country dynamics
Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 France key country dynamics
Fig. 54 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Italy key country dynamics
Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Spain key country dynamics
Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Denmark key country dynamics
Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Sweden key country dynamics
Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Norway key country dynamics
Fig. 64 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 China key country dynamics
Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Japan key country dynamics
Fig. 69 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 India key country dynamics
Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Thailand key country dynamics
Fig. 73 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 South Korea key country dynamics
Fig. 75 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Australia key country dynamics
Fig. 77 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Brazil key country dynamics
Fig. 80 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Argentina key country dynamics
Fig. 82 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 South Africa key country dynamics
Fig. 85 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Saudi Arabia key country dynamics
Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 UAE key country dynamics
Fig. 89 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Kuwait key country dynamics
Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Market share Analysis of key market players, 2024